Mounjaro (Tirzepatide GLP-1 Agonist) is the latest innovative dual-action injectable treatment primarily used for treating type 2 diabetes and has also shown strong secondary effectiveness in weight loss.

The rising rates of obesity in Malaysia present a significant public health challenge. With obesity affecting a large segment of the population, it’s vital to explore the statistics, risk factors, and potential treatments to effectively tackle this issue. This post will examine the weight loss landscape in Malaysia, shedding light on key statistics, causal factors behind weight gain, and available treatments for those striving to lose weight. Weight Loss Statistics for the Ma